Scleroderma and dermatomyositis
Meinhof, W.
Die Medizinische Welt 23(45): 1650-1653
1972
ISSN/ISBN: 0025-8512 PMID: 4637705 Document Number: 44240
Document emailed within 1 workday
Related Documents
Ofuji, T. 1978: Clinicopathological studies of SLE, scleroderma and dermatomyositis associated with vasculitis Nihon Rinsho. Japanese Journal of Clinical Medicine 36(4): 747-752Debreczeni, M.; Ladányi, E. 1970: Determination of creatine-phosphokinase in patients with scleroderma and dermatomyositis Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 21(2): 81-82
Hom, C.; Ilowite, N.T. 1998: Other rheumatic diseases in adolescence. Dermatomyositis, scleroderma, overlap syndromes, systemic vasculitis, and panniculitis Adolescent Medicine 9(1): 69-83 Vi
Ziegler, V.; Haustein, U.F.; Mehlhorn, J.; Münzberger, H.; Rennau, H. 1986: Quartz-induced scleroderma. Scleroderma-like syndrome or true progressive scleroderma? Dermatologische Monatschrift 172(2): 86-90
Krajnc, I. 1999: Dermatomyositis. Diagnosis and evaluation of dermatomyositis, polymyositis, and inclusion-body myositis Advances in Experimental Medicine and Biology 455: 181-186
Ishikawa, H.; Suzuki, S.; Horiuchi, R.; Sato, H. 1975: An approach to experimental scleroderma, using urinary glycosaminoglycans from patients with systemic scleroderma Acta Dermato-Venereologica 55(2): 97-107
De la Espriella, J.; Crickx, B. 1991: Scleroderma and environment. I. Scleroderma and sclerodermiform states induced by silica and chemical agents or drugs Annales de Dermatologie et de Venereologie 118(12): 948-953
Giordano, M.; Valenti, G. 1986: Linear scleroderma plus systemic sclerosis sine scleroderma plus neuromyopathy of one upper limb: a new entity? Journal of Rheumatology 13(3): 656-657
Pope, J.E.; Bellamy, N. 1995: Sample size calculations in scleroderma: a rational approach to choosing outcome measurements in scleroderma trials Clinical and Investigative Medicine 18(1): 1-10
Kochetov, D.P.; Krivosheev, B.N. 1976: Scleroderma and porphyria cutanea tarda with clinical manifestations of scleroderma Vestnik Dermatologii i Venerologii 1: 64-68
Jablonska, S.; Blaszczyk, M. 1999: Scleromyxedema is a scleroderma-like disorder and not a coexistance of scleroderma with papular mucinosis European Journal of Dermatology: Ejd 9(7): 551-554
Madsen, K.L.; Hansen, A.; Halberg, P.; Ullman, S. 2014: Development of scleroderma renal crisis in a patient with undiagnosed scleroderma Ugeskrift for Laeger 176(25a)
Black, C.M. 1994: Prognosis and management of scleroderma and scleroderma-like disorders in children Clinical and Experimental Rheumatology 12(Suppl 10): S75-S81
Haustein, U.F.; Ziegler, V. 1986: Scleroderma and scleroderma-like diseases caused by environmental pollutants Dermatosen in Beruf und Umwelt. Occupation and Environment 34(3): 61-67
Ziegler, V.; Pampel, W.; Zschunke, E.; Münzberger, H.; Mährlein, W.; Köpping, H. 1982: Crystalline quartz--one cause of progressive scleroderma? Epidemiologic studies on the simultaneous appearance of progressive scleroderma and silicosis Dermatologische Monatschrift 168(6): 398-401
Dubois, E.L.; Chandor, S.; Friou, G.J.; Bischel, M. 1971: Progressive systemic sclerosis and localized scleroderma morphea with positive lupus erythematosus cell test and unusual systemic manifestations compatible with systemic lupus erythematosus presentation of 14 cases including 1 set of identical twins 1 with scleroderma and the other with systemic lupus erythematosus review of the literature Medicine (Baltimore) 50(3): 199-222
Rozhold, O.; Györgyová, E. 1973: Dermatomyositis Ceskoslovenska Neurologie 36(3): 156-161
O'Brien, J.; Kelleher, J. 2008: Calcinosis associated with dermatomyositis JBR-BTR: Organe de la Societe Royale Belge de Radiologie 91(1): 27
Pellissier, J.F.; Civatte, M.; Fernandez, C.; Bartoli, C.; Chetaille, B.; Schleinitz, N.; Figarella-Branger, D. 2002: Dermatomyositis and polymyositis Revue Neurologique 158(10 Part 1): 934-947
Filo, V. 2003: Amyopathic dermatomyositis Casopis Lekaru Ceskych 142(11): 648-650